HKSE - Delayed Quote HKD

Zhejiang Taimei Medical Technology Co., Ltd. (2576.HK)

Compare
3.170
+0.070
+(2.26%)
At close: 4:08:06 PM GMT+8

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
NameTitlePayExercisedYear Born
Mr. Zhao Lu Executive Chairman 4.1M -- 1979
Ms. Xiaomei Ni Executive Director, Legal Director & Board secretary 1.69M -- 1972
Mr. Yufei Huang Executive Director & Head of the operations assurance division 1.84M -- 1979
Mr. Hongwei Zhang Head of Digital Marketing Division & Executive Director 1.34M -- 1980
Mr. Dong Ma Chief Product Officer & Director 2.5M -- 1983
Ms. Yunyun Wan General Manager -- -- 1985
Mr. Chengwen Jiang Chief Financial Officer -- -- 1982
Mr. Yiming Lu CTO & Director -- -- 1981
Mr. Ping Yeung Poon Joint Secretary -- -- --

Zhejiang Taimei Medical Technology Co., Ltd.

No.9 Building
3F Jiaxing Intellectual Industry Innovation Park No.36 South Changsheng Road
Jiaxing, 314000
China
86 573 82682386 https://www.taimei.com
Sector: 
Healthcare
Full Time Employees: 
627

Description

Zhejiang Taimei Medical Technology Co., Ltd. provides digital operation platform for the biopharma industry in China. The company offers TrialOS, a drug digital cooperation platform that connects the cycle of hospitals, pharmaceutical companies, third-party providers, regulatory authorities, patients, and other industry stakeholders. It offers software solutions, such as eCooperate, a clinical trial cooperation platform that optimizes clinical research operations management systems, as well as support decision-making with big data technology; eArchives, a clinical trial master file system; eCollect, an electronic data capture system; eCollege, a training management system; eQuality, an electronic quality audit system; eBalance, an interactive Web-based response system; eVisit Patient Reported Outcomes, a solution that enhances the ability of patients to enter data and the accuracy of clinical trial data; eTime, a project man-hour management system; and eImage, a medical image reading system. It also provides hospital software, including eTrial, a phase I ward management system; eSite, a clinical trial management system for GCP sites; GCP-X, an intelligent clinical trial platform; NomenCTMS, a clinical research project management system for GCP sites; eScreening, a subject information management and duplicate checking system; Intelligent Investigator, an initiated clinical trial platform; IIT-EDC, a clinical research data management platform; and Investigator-Initiated Clinical Trial Management System, a project management system. In addition, the company offers pharmacovigilance software solutions, such as eSafety global pharmacovigilance system; eSafety, an intelligent professional information system for pharmacovigilance; and SAE Manager, a safety data communication and management system for clinical trials. Further, it provides marketing software and digital innovation solutions. The company was founded in 2013 and is headquartered in Jiaxing, China.

Corporate Governance

Zhejiang Taimei Medical Technology Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events